Skip to main content
Caplight Logo









Burst Diagnostics

Burst Diagnostics

Private
Fort Collins, ColoradoHealthcare & Life Scienceshttps://burst-dx.com/

Last Round

Grant

Oct 29, 2025

Total Funding Raised

$830,856

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Burst Diagnostics is a medical devices and equipment company that develops rapid, paper-based, point-of-care diagnostic test platforms designed to provide quantitative, lab-quality results.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Application

Keywords

point-of-care diagnosticsPOC testingmicrofluidicsdiagnostic platformmedical devicelab-on-a-chipdiagnostic consumablesrapid testingchemiluminescent assayOEM diagnostic partnerat-home diagnosticsdigital healthmachine visionSBIR grants

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Burst Diagnostics Comparables

Compare Burst Diagnostics with similar companies based on industry and business-model similarity.

Burst Diagnostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Chronus Health
88%
FluxErgy
82%
QuantuMDx
77%

Burst Diagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 29, 2025
Seed RoundJan 19, 2024
GrantSep 19, 2023
GrantMay 18, 2023
SeedMar 2, 2023

Burst Diagnostics Investors

Notable investors and investment history

Burst Diagnostics investors
InvestorRounds
Advanced Industries Accelerator ProgramGrant
National Institutes of Health (NIH)Grant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 29, 2025

    $301K grant received from the National Institutes of Health.

  • Sep 19, 2023

    $280K grant received from the National Institutes of Health.

Burst Diagnostics Filings

Explore SEC and related filing metadata, where available.

Burst Diagnostics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Burst Diagnostics's valuation, stock price, and market status.

Is Burst Diagnostics a public or private company?

Burst Diagnostics is a private company.

What is the current stock price of Burst Diagnostics?

Burst Diagnostics is a private company with no public stock price. No recent secondary market data is available.

How much is Burst Diagnostics worth (valuation)?

Valuation information for Burst Diagnostics is not publicly available.

Can I buy Burst Diagnostics stock?

Burst Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Burst Diagnostics's last funding round?

Burst Diagnostics's most recent funding round was Seed Round on January 19, 2024.

Who are the main investors in Burst Diagnostics?

Investor information for Burst Diagnostics is not publicly disclosed.

Will Burst Diagnostics IPO soon?

No public IPO plans have been announced for Burst Diagnostics.

How can I track Burst Diagnostics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Burst Diagnostics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersFort Collins, Colorado
Employee Range19
Year Founded2020
Last FundingOct 29, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?